US 7223388
Modified reoviral therapy
granted A61KA61K35/765A61K47/6901
Quick answer
US patent 7223388 (Modified reoviral therapy) held by The Board of Regents of the University of Texas System expires Mon May 24 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue May 29 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 24 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K35/765, A61K47/6901, A61P, A61P19/02